Congress - Washington, DC, United States
TAT congresses are annual meetings on new molecular targets and innovative cancer therapeutics in the early phases of clinical development, supplemented by associated translational research. Add to these features the high scientific standards, informal atmosphere, and active participation by the world’s leading phase 1 investigators, and you will understand why the TAT Congress series has become the prime international drug development meeting in oncology.
TAT Congresses are more than regular meetings of drug development professionals from academia and pharma and biotech industry. They are the place where the world’s leaders in early-phase development of new cancer therapeutics gather annually, establish and re-new professional and personal relationships, exchange views, discuss matters of common interest, and establish new collaborations.
Organization: Congress by design
Mon, Mar 21, 2016 - Wed, Mar 23, 2016
Omni Shoreham Hotel
2500 Calvert Street, Washington, DC 20008, Washington, United States
If you'd like to ask a question or post a comment about this talk please do so below.
This seminar posting is brought to you by Biotechnology Calendar, Inc. providing access to research information and research tools for nearly 20 years. Visit our Science Market Update Blog for current science funding and market information or see our schedule of upcoming science research laboratory product shows.
